Evaluating the use of elastography in endobronchial ultrasound technique as a diagnostic approach for mesothorax lymphadenopathy. (2nd December 2019)

• Record Type: Journal Article
• Authors: Zarogoulidis, Paul; Sapalidis, Konstantinos; Fyntanidou, Varvara; Kosmidis, Christoforos; Amaniti, Aikaterini; Koulouris, Charilaos; Giannakidis, Dimitrios; Tsakiridis, Kosmas; Aidoni, Zoi; Romanidis, Konstantinos; Oikonomou, Panagoula; Huang, Haidong; Freitag, Lutz; Hohenforst-Schmidt, Wolfgang
• Is Part Of: Expert review of respiratory medicine. Volume 13:Number 12(2019)
• Page Start: 1153
• Page End: 1159
• Publication Date: 2019-12-02
• Subjects: Lung cancer -- NSCLC -- endobronchial ultrasound -- EBUS -- elastography -- strain ratio; Respiratory organs -- Diseases -- Periodicals; Respiratory organs -- Diseases -- Treatment -- Periodicals; 616.2005
• DOI: 10.1080/17476348.2019.1677466
• Languages: English
• ISSNs: 1747-6348

Abstract

ABSTRACT: Introduction : Non-small cell lung cancer is still diagnosed at a late stage although we have new diagnostic equipment such the radial endobronchial ultrasound, convex probe endobronchial ultrasound, and electromagnetic navigation. The diagnostic techniques have been upgraded with rapid on-site evaluation (ROSE) and currently from 2014 real-time elastography is being evaluated as a ROSE technique. Areas covered : A thorough search was performed on PubMed and Scopus with the following key words: elastography, strain ratio, convex probe EBUS, endoscopic ultrasound (EUS), elastography. In the current mini review, we will focus on published data regarding elastography with the convex probe endobronchial ultrasound in two different systems and comment on this future ROSE technique. Elastography, strain ratio, and factors such as(I) margin (indistinct or distinct); (II) shape (oval or round); (III) short-axis size less or more than 1 cm; (IV) presence or absence of central hilar structure (CHS); (V) echogenicity (homogeneous or heterogeneous); and (VI) presence or absence of coagulation necrosis sign are presented in our review based on published literature. Expert opinion : Current data indicate that we can have up to 93% sensitivity and specificity of real-time elastography and strain ratio for the evaluation of benignancy and malignancy; however, sample biopsy is still necessary. For now, we can only reduce the number of punctures.